Immunohistochemical evaluation of proliferating cell nuclear antigen, prostate-specific antigen and α1-antichymotrypsin in human prostate cancer

British Journal of Urology

Volumn 77, Issue 1, 1996, Pages 107-112

  Igawa, M ^a   Urakami, S ^a   Shiina, H ^a   Ishibe, T ^a   Shirane, T ^a   Usui, T ^a   Chodak, G W ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Proliferating cell nuclear antigen; Prostate cancer; Prostatespecific antigen; 1 antichymotrypsin

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; CYCLINE; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; CLINICAL ARTICLE; HUMAN TISSUE; PRIORITY JOURNAL; PROSTATE CANCER;

ALPHA 1-ANTICHYMOTRYPSIN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROLIFERATING CELL NUCLEAR ANTIGEN; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0029665671     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1996.82418.x     Document Type: Article

References (15)

1. Gleason DF, Mellinger GT. The Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974; 111: 58-64
2. Kozlowski JM, McEwan R, Keer H et al. Prostate cancer and the invasive phenotype: application of new in viva and m vitro approaches. In Tumor Progression and Metastasis. New York: Alan R. Liss Inc. 1988: 189-231
3. Allhoff EP, Proppe KH, Chapman CM, Lin C-W, Proud GR Jr. Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer. J Urol 1983; 129: 315-8
4. Gallee MPW, Visser-de Jong E, van der Korput JAGM et al. Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens. Urol Res 1990: 18: 181-7
5. Ban Y, Wang MC, Watt KWK, Loor R, Chu TM. The proteolytic activity of human prostate-specific antigen. Biochem Biophysic Res Commun 1984: 123: 482-8
6. Guinan P, Bhatti R, Ray P. An evaluation of prostate specific antigen in prostatic cancer. J Urol 1987; 137: 686-9
7. Christensson A, Laurell CB, Lilja H. Enzymatic activity of prostate-specific antigen and its reaction with extracellular serine proteinase inhibitors. Eur J Biochem 1990: 194: 755-63
8. Lilja H, Christensson A. Dahlen U et al. Prostate-specific antigen in serum occurs predominantly in complex with alpha-1-antichymotrypsin. Clin Chem 1991: 37: 1618-25
9. Kurki P, Vanderlaan M. Dolbeare F, Gray J, Tan EM. Expression of proliferating cell nuclear antigen (PCNA)/ cyclin during the cell cycle. Exp Cell Res 1986: 166: 209-19
10. Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep 1966: 50: 125-8
11. Gallee MPW. Visser-de Jong E. ten Kate FJW. Schroeder FH, van der Kwast ThH. Monoclonal antibody Ki-67 defined growth fraction in benign prostatic hyperplasia and prostatic cancer. J Urol 1989; 142: 1342-6
12. Abrahamsson P-A, Lilja H, Falkmer S, Wadstrom LB. Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate gland. Prostate 1988; 12: 39-46
13. 3 Christensson A. Bjork T. Nilsson O et al. Serum prostate specific antigen complexed to 1-antichymotrypsin as an indicator of prostate cancer. J Urol 1993; 150: 100-5
14. Bjartell A. Bjork T, Matikainen MT. Abrahamsson PA. di Sant'Agnese A, Lilja H. Production of alpha-1-antichymotrypsin by PSA-containing cells of human prostate epithelium. Urology 1993; 42: 502-10
15. Tahara E, Ito H, Taniyama K, Yokozaki H. Hata J. Alpha 1-antitrypsin, alphal-antichymotrypsin, and alpha2-macroglobulin in human gastric carcinomas: a retrospective immunohistochemical study. Hum Pathol 1984; 15: 957-64